Dr. Chad A. Lagrange, MD

Dr. Lagrange practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Lagrange's NPI, 1962592873, was assigned on October 13, 2006. Dr. Lagrange graduated from University of Missouri, Kansas City, School of Medicine in 2001. Dr. Lagrange holds Kentucky license 40187.

Dr. Lagrange's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Lagrange also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Lagrange's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Lagrange is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Lagrange to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lagrange practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lagrange's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lagrange is licensed in Kentucky.

CMS data shows 865 Medicare services from Dr. Lagrange across 17 procedure codes in 2024, for 544 Medicare patients. Medicare paid $75,167 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 544 Medicare patients who saw Dr. Lagrange in 2024. The largest group is 65 to 74, with 289 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lagrange's median patient age at 72, with 20% women.

In 2024, Dr. Lagrange wrote 819 Medicare Part D claims for 218 patients. 91% of them were for generic drugs. CMS names the drug for 689 of them, across 15 drugs with 11 or more claims each, at $54,976 in total drug cost. In 2023, CMS named 763 claims across 15 drugs.

Dr. Lagrange accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lagrange as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Lagrange, more than 69% of the clinicians it reports for that procedure.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 43 general payments to Dr. Lagrange from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Integer Holdings Corporation paid the most, $7,850.

Dr. Lagrange graduated from University of Missouri, Kansas City, School of Medicine in 2001.